These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6451788)

  • 41. [Pharmacokinetic studies of piperacillin after 4 g or 8 g intravenous injection in human healthy volunteers].
    Nakagawa K; Yasuda T; Nakajima Y; Watanabe Y; Noguchi M; Suzuki T
    Jpn J Antibiot; 1982 Dec; 35(12):2797-804. PubMed ID: 6222208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.
    Fortner CL; Finley RS; Schimpff SC
    Pharmacotherapy; 1982; 2(6):287-99. PubMed ID: 6220262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of piperacillin in patients on peritoneal dialysis with and without peritonitis.
    Debruyne D; Ryckelynck JP; Hurault De Ligny B; Moulin M
    J Pharm Sci; 1990 Feb; 79(2):99-102. PubMed ID: 2324971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
    Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y
    Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing.
    Burgess DS; Waldrep T
    Clin Ther; 2002 Jul; 24(7):1090-104. PubMed ID: 12182254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration.
    Arzuaga A; Maynar J; Gascón AR; Isla A; Corral E; Fonseca F; Sánchez-Izquierdo JA; Rello J; Canut A; Pedraz JL
    J Clin Pharmacol; 2005 Feb; 45(2):168-76. PubMed ID: 15647409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
    Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
    Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).
    van der Werf TS; Mulder PO; Zijlstra JG; Uges DR; Stegeman CA
    Intensive Care Med; 1997 Aug; 23(8):873-7. PubMed ID: 9310805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Piperacillin kinetics.
    Batra VK; Morrison JA; Lasseter KC; Joy VA
    Clin Pharmacol Ther; 1979 Jul; 26(1):41-53. PubMed ID: 445961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients.
    Manley HJ; Bailie GR; Frye R; McGoldrick MD
    Perit Dial Int; 2000; 20(6):686-93. PubMed ID: 11216560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetics of larger doses of penicillin].
    Rudzit EA; Nefedova ZV
    Antibiotiki; 1969 Aug; 14(8):725-9. PubMed ID: 5378157
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of piperacillin-tazobactam on pharmacokinetics of gentamicin given once daily.
    Hitt CM; Patel KB; Nicolau DP; Zhu Z; Nightingale CH
    Am J Health Syst Pharm; 1997 Dec; 54(23):2704-8. PubMed ID: 9408514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Piperacillin/Tazobactam inducing seizures in a hemodialysed patient.
    Bassilios N; Restoux A; Vincent F; Rondeau E; Sraer JD
    Clin Nephrol; 2002 Oct; 58(4):327-8. PubMed ID: 12400853
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
    Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
    Ward S; Boheimer N; Weatherley BC; Simmonds RJ; Dopson TA
    Br J Anaesth; 1987 Jun; 59(6):697-706. PubMed ID: 3606914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The penicillins and bone penetration of antibiotics.
    LeFrock J; Smith BR
    J Foot Surg; 1987; 26(1 Suppl):S34-41. PubMed ID: 3559053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.